From its establishment in 2005, J-Pharma, a clinical stage bio-venture company with a special focus on membrane transporters, has been conducting an array of unique drug developments by Hitoshi Endou, MD., Ph.D., formerly a professor of Kyorin University Faculty of Medicine. Recently J-Pharma has been placing the highest priority on the clinical development of its original inhibitors of L-type amino acid transporter 1 (“LAT1”) for the treatment of advanced cancer patients who failed to benefit from standard chemotherapy.
Company Details
- Employees
- 16
- Founded
- -
- Address
- 75-1 Onocho, Tsurumi-Ku, Yokohama,japan
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.j-pharma.com/en/
- Keywords
- Irvine.
- HQ
- Yokohama
J-Pharma Questions
J-Pharma's website is http://www.j-pharma.com/en/
J-Pharma's LinkedIn profile is https://jp.linkedin.com/company/j-pharma
J-Pharma has
16 employees.
View email and phone details for 16
employees at J-Pharma.
J-Pharma's industry is
Pharmaceutical Manufacturing
J-Pharma's top competitors are
G-Pharma,
Alcon Laboratories Corporate Health Services,
Crafton Biotechnology Co., Ltd.,
Laboratoires Medgen,
Vetscope,
Gpharma,
Rhenochem Brasil,
Jpharma,
Horstman Usa,
Huonslab.
J-Pharma's categories are Pharmaceutical Manufacturing
J-Pharma's founding year is 2005
